GlassScriptPhysician profile
Michael O'Brien
NPI 1801090121
$4,547.16
in general payments reported to CMS, 2019-2025
23 companies · $787 in 2025
The $787 reported for 2025 was more than what 76% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $888 · 2022: $2,020 · 2023: $448 · 2024: $403 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,185 · Travel and Lodging: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.56 |
| Travel and Lodging | $454.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,483.71 | 2022-2023 | Signia, Octopus |
| Getinge USA Sales, LLC | $928.32 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Abbott Laboratories | $524.46 | 2021-2023 | Proclaim |
| Atricure, INC. | $479.50 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Baxter Healthcare | $209.55 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2025 | Farxiga |
| Abiomed | $101.79 | 2025 | |
| Intuitive Surgical, INC. | $99.75 | 2021 | |
| Novo Nordisk INC | $89.60 | 2024 | Ozempic, Rybelsus |
| Janssen Scientific Affairs, LLC | $88.67 | 2022 | |
| Haemonetics Corporation | $51.62 | 2021 | |
| Depuy Synthes Sales INC. | $42.73 | 2022 | |
| Ethicon INC. | $40.08 | 2022 | |
| Chiesi USA, INC. | $39.33 | 2021-2023 | Cleviprex, Kengreal |
| W. L. Gore & Associates, INC. | $31.10 | 2023 | Gore Tag Conformable Thoracic Endoprosthesis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $28.90 | 2024 | Echelon Endopath, Echelon Flex, Surgicel Nu-Knit |
| Convatec INC. | $28.20 | 2022 | |
| Angiodynamics, INC. | $28.00 | 2022 | |
| Edwards Lifesciences Corporation | $27.83 | 2021 | |
| Corcym INC | $26.43 | 2021 | |
| Kls-Martin L.P. | $26.05 | 2024 | |
| La Jolla Pharmaceutical Company | $25.30 | 2022 | |
| Grifols USA, LLC | $21.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael O'Brien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.